ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CVS CVS Health Corporation

55.80
-0.17 (-0.30%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
CVS Health Corporation NYSE:CVS NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.17 -0.30% 55.80 57.09 55.58 55.59 17,486,991 01:00:00

CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business

20/03/2018 2:32pm

Dow Jones News


CVS Health (NYSE:CVS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more CVS Health Charts.
By Sharon Terlep 

CVS Health Corp. tapped a former Eli Lilly & Co. finance chief to run its pharmacy benefit business as the drugstore giant works to complete an acquisition of insurer Aetna Inc.

Longtime Eli Lilly CFO Derica Rice is set to take over CVS Caremark on March 30, according to an internal CVS memo reviewed by The Wall Street Journal. Mr. Rice will replace Jonathan Roberts, who was promoted last year to the role of chief operating officer.

"With growing concerns over the affordability of prescriptions, the role of the pharmacy benefit manager has never been more important to the healthcare system," CVS said in the memo, announcing the appointment to managers.

Pharmacy-benefit managers are middlemen in health care that help select which drugs are covered for patients and negotiate discounts with drugmakers.

CVS, with its $69 billion acquisition of Aetna, aims to create a vertical healthcare enterprise in which pharmacists are central to patient care and the company's vast network of drug stores will provide services from lab testing to infusion of specialty medications.

Mr. Rice worked at Lilly for about 27 years and served as chief financial officer from 2006 until retiring in December. He served as interim CEO at the Indianapolis drug maker for a few months in 2013 when then-CEO John Lechleiter took a medical leave.

Mr. Rice helped craft Lilly's strategy to weather a period of patent expirations for top-selling drugs that caused the company's sales to decline sharply in 2014. The company cut costs and licensed rights to new drugs to help offset some of the sales decline.

Write to Sharon Terlep at sharon.terlep@wsj.com

 

(END) Dow Jones Newswires

March 20, 2018 10:17 ET (14:17 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

1 Year CVS Health Chart

1 Year CVS Health Chart

1 Month CVS Health Chart

1 Month CVS Health Chart

Your Recent History

Delayed Upgrade Clock